Brief: EBR Systems Provides Update On FDA Review Of Cybersecurity Incident
09/09/2026 02:34
BRIEF-EBR Systems Provides Update On FDA Review Of Cybersecurity Incident Sept 9 (Reuters) - EBR Systems Inc EBR.AX:
EBR PROVIDES UPDATE ON FDA REVIEW OF CYBERSECURITY INCIDENT
FDA AGREES NO FIELD CORRECTIVE ACTION OR RECALL FOR WISE SYSTEM
INCIDENT CLASSIFIED AS CONTROLLED RISK UNDER FDA CYBERSECURITY GUIDANCE
NO EVIDENCE OF IMPACT TO WISE CRT SYSTEM SAFETY OR PERFORMANCE
CONTINUES CYBERSECURITY REMEDIATION AND HARDENING ACTIVITIES
Further company coverage: EBR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026